Alginate-based oral drug delivery system for tuberculosis: Pharmacokinetics and therapeutic effects

Journal of Antimicrobial Chemotherapy

Volumn 51, Issue 4, 2003, Pages 931-938

  Qurrat ul Ain, A ^a   Sharma, Sadhna ^a   Khuller, G K ^a   Garg, S K ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Alginate; Antitubercular drugs; Drug delivery; Pharmacokinetics; Tuberculosis

Indexed keywords

ALGINIC ACID; DRUG CARRIER; ISONIAZID; MICROSPHERE; PYRAZINAMIDE; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; COLONY FORMING UNIT; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG RELEASE; EXPERIMENTAL INFECTION; HISTOPATHOLOGY; IN VITRO STUDY; IN VIVO STUDY; LUNG HOMOGENATE; MICROENCAPSULATION; NONHUMAN; PATIENT COMPLIANCE; SPLEEN; STATISTICAL SIGNIFICANCE; TUBERCULOSIS;

ADMINISTRATION, ORAL; ALGINATES; ANIMALS; ANTIBIOTICS, ANTITUBERCULAR; ANTITUBERCULAR AGENTS; AREA UNDER CURVE; DRUG COMPOUNDING; EXCIPIENTS; GUINEA PIGS; HALF-LIFE; HYDROGELS; ISONIAZID; PNEUMOCOCCAL INFECTIONS; PYRAZINAMIDE; RIFAMPIN; SOLUBILITY;

EID: 0037392675     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkg165     Document Type: Article

References (23)

1. Fox, W. (1983). Compliance of patients and physicians: experiences and lessons from tuberculosis - II. British Medical Journal 287, 101-5.
2. Deol, P., Khuller, G. K. & Joshi, K. (1997). Therapeutic efficacies of isoniazid and rifampicin encapsulated in lung specific stealth liposomes against Mycobacterium tuberculosis infection induced in mice. Antimicrobial Agents and Chemotherapy 41, 1211-4.
3. Dutt, M. & Khuller, G. K. (2000). Poly (DL-lactide-co-glycolide) microparticles as carriers for antimycobacterial drug rifampicin. Indian Journal of Experimental Biology 38, 887-94.
4. Longer, M. A., Ching, H. S. & Robinson, J. R. (1985). Bioadhesive polymers as platforms for oral controlled drug delivery III: oral delivery of chlorothiazide using a bioadhesive polymer. Journal of Pharmaceutical Sciences 74, 406-11.
5. Chickering, D. E., Jacob, J. S., Desia, T. A., Harrison, M., Harris, W. P., Morell, C. N. et al. (1997). Bioadhesive polymers III. An in vivo transit and bioavailability study of drug loaded alginate and poly (fumaric-co-sebacic anhydride) microspheres. Journal of Controlled Release 48, 35-46.
6. Ramadas, M., Paul, W., Dileep, K. J., Anitha, Y. & Sharma, C. P. (2000). Lipoinsulin encapsulated alginate-chitosan capsules. Intestinal delivery in diabetic rats. Journal of Microencapsulation 4, 405-11.
7. Hari, P. R., Chandy, T. & Sharma, C. P. (1996). Chitosan-calcium alginate micro capsules for intestinal delivery of insulin. Journal of Microencapsulation 13, 319-29.
8. Takagi, I., Shimazu, H. & Yotsunagi, T. (1996). Application of alginate gel as a vehicle for liposomes I. Factors affecting the loading of drug-containing liposomes and drug release. Chemical and Pharmaceutical Bulletin 44, 1941-7.
9. Takka, S. & Acarturk, F. (1999). Calcium alginate microparticles for oral administration. The effect of sodium alginate type on drug release and drug entrapment efficiency. Journal of Microencapsulation 16, 275-90.
10. Scott, E. H. & Wright, R. C. (1967). Fluorimetric determination of isonicotinic acid hydrazide in serum. Journal of Laboratory and Clinical Medicine 70, 355-60.
11. Gurumurthy, P., Nair, N. G. K. & Sarma, G. R. (1980). Methods for the estimation of pyrazinamide and pyrazinoic acid in body fluids. Indian Journal of Laboratory and Clinical Medicine 71, 129-34.
12. Saito, H. & Tomoika, H. (1989). Therapeutic efficacy of liposome-entrapped rifampicin against M. avium complex infections induced in mice. Antimicrobial Agents and Chemotherapy 33, 429-33.
13. Naganathan, N., Mahadev, B., Challu, V. K., Rajlakshmi, R. & Jones, B. (1986). Virulence of tubercle bacilli isolated from patients with tuberculosis in Bangalore, India. Tubercle 67, 261-7.
14. Yotsuyanagi, T., Oskubo, T., Ohhashi, T. & Ikeda, K. (1986). Calcium induced gelation of alginic acid and pH re-swelling of dried gels. Chemical and Pharmaceutical Bulletin 35, 1555-63.
15. Nascimento, A., Laranjeira, M. C. M., Favere, V. T. & Josue, A. (2001). Impregnation and release of aspirin from chitosan/poly-(acrylic acid) graft copolymer microspheres. Journal of Microencapsulation 18, 679-84.
16. Ain, Q., Sharma, S., Garg, S. K. & Khuller, G. K. (2002). Role of poly (DL-lactide-co-glycolide) in development of a sustained oral delivery system for antitubercular drug(s). International Journal of Pharmaceutics 238, 123-32.
17. Keung, A., Eller, M. G., Mekenzie, K. A. & Weir, S. J. (1999). Single and multiple dose pharmacokinetics of rifapentine in man: Part II. International Journal of Lung Diseases 5, 437-44.
18. Dutt, M. & Khuller, G. K. (2001). Chemotherapy of mycobacterial infections in mice by a combination of antitubercular drugs entrapped in poly (DL-lactide-co-glycolide) microparticles. Journal of Antimicrobial Chemotherapy 47, 829-35.
19. Dhillon, J., Dickinson, J. M., Sole, K. & Mitchison, D. A. (1996). Preventive chemotherapy of tuberculosis in Cornell model mice with combinations of rifampin, isoniazid, and pyrazinamide. Antimicrobial Agents and Chemotherapy 40, 552-5.
20. Lenaert, A. M., Chase, S. E., Chmielewski, A. J. & Cynamon, M. H. (1999). Evaluation of rifapentine in long-term treatment regimens for tuberculosis in mice. Antimicrobial Agents and Chemotherapy 43, 2356-60.
21. Tripathy, S. P. (1976). A slow release preparation of isoniazid: therapeutic efficacy and adverse side effects. Bulletin of the International Union against Tuberculosis 51, 133-41.
22. Polansky, F., Viznerova, S., Vodrazkova, A. & Scott, H. (1976). Clinical experience of acceptability of slow release matrix isoniazid. Bulletin of the International Union against Tuberculosis 51, 155-8.
23. Ellard, G. A. (1976). A slow release preparation of isoniazid: pharmacological aspects. Bulletin of the International Union against Tuberculosis 51, 143-54.